Shin Hee Hong
Overview
Explore the profile of Shin Hee Hong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
252
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jeong W, Kim B, Hong S, Cho E, Kim S, Moon J
PLoS One
. 2024 Oct;
19(10):e0312300.
PMID: 39446762
Objective: Given the critical importance of maternal mental health for the well-being of both the mother and fetus, it is essential to thoroughly investigate the impact of COVID-19 infection on...
2.
Chung Y, Kim E, Kim H, Park K, Baek J, Kim J, et al.
J Korean Med Sci
. 2022 Oct;
37(41):e297.
PMID: 36281486
Background: This study aimed to describe the maternal, obstetrical, and neonatal outcomes in pregnant women with coronavirus disease 2019 (COVID-19) and identify the predictors associated with the severity of COVID-19....
3.
Hong S, Shi H, Kim S, Park Y, Eom J
Infect Chemother
. 2022 Aug;
54(3):433-445.
PMID: 35920268
Background: Coronavirus disease 2019 (COVID-19) during pregnancy is associated with increased disease severity and an increased risk of perinatal complications. However, few studies of pregnant women with COVID-19 have been...
4.
Shi H, Nham E, Kim B, Joo E, Cheong H, Hong S, et al.
J Korean Med Sci
. 2022 Jun;
37(22):e175.
PMID: 35668685
Background: Numerous patients around the globe are dying from coronavirus disease 2019 (COVID-19). While age is a known risk factor, risk analysis in the young generation is lacking. The present...
5.
Kim S, Hong S, Park Y, Sung J, Suh W, Lee K, et al.
Sci Rep
. 2019 Feb;
9(1):1656.
PMID: 30733541
Peroxisome proliferator-activated receptor (PPAR)-α/γ dual agonists have been developed to treat metabolic diseases; however, most of them exhibit side effects such as body weight gain and oedema. Therefore, we developed...
6.
Cho E, Ryu J, Lee H, Hong S, Park H, Hong K, et al.
J Nanobiotechnology
. 2019 Jan;
17(1):19.
PMID: 30696428
Background: Protein-based Cas9 in vivo gene editing therapeutics have practical limitations owing to their instability and low efficacy. To overcome these obstacles and improve stability, we designed a nanocarrier primarily...
7.
Ahn S, Hong S, Park Y, Jung S, Song J, Park Y, et al.
Clin Exp Rheumatol
. 2018 Jan;
36(4):533-539.
PMID: 29352840
Objectives: Secreted aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1) has been reported to have pro-inflammatory properties. The aim of this study was to evaluate the clinical significance of serum AIMP1 in patients...
8.
Hong S, Yoon K, Lim K, Um Y, Cho J, Jo Y, et al.
Biochem Biophys Res Commun
. 2016 Sep;
478(4):1682-7.
PMID: 27596970
Tauroursodeoxycholic acid (TUDCA) is known to prevent apoptosis through the Bax pathway and to promote neovascularization by enhancing the mobilization of stem cells, their differentiation. This study was performed to...
9.
Hong S, Cho J, Yoon K, Lim D, Kim C, Lee S, et al.
Biomaterials
. 2015 Jan;
44:45-54.
PMID: 25617125
ARS-interacting multifunctional protein 1 (AIMP1) induces production of inflammatory cytokines from immune cells. Since osteoclastogenesis is promoted by positive regulation of inflammatory cytokines, whether AIMP1 could promote osteoclastogenesis was investigated....
10.
Cho J, Lee J, Hong S, Lee H, Kim C, Kim S, et al.
Stem Cells
. 2014 Nov;
33(3):792-805.
PMID: 25407160
Although serum bile acid concentrations are approximately 10 µM in healthy subjects, the crosstalk between the biliary system and vascular repair has never been investigated. In this study, tauroursodeoxycholic acid...